Kelly DL - Search Results

1

Relief of cannabis withdrawal symptoms and cannabis quitting strategies in people with schizophrenia.

Koola MM, Boggs DL, Kelly DL, Liu F, Linthicum JA, Turner HE, McMahon RP, Gorelick DA. Koola MM, et al. Among authors: kelly dl. Psychiatry Res. 2013 Oct 30;209(3):273-8. doi: 10.1016/j.psychres.2013.07.044. Epub 2013 Aug 20. Psychiatry Res. 2013. PMID: 23969281 Free PMC article.

2

Novel factor-based symptom scores in treatment resistant schizophrenia: implications for clinical trials.

McMahon RP, Kelly DL, Kreyenbuhl J, Kirkpatrick B, Love RC, Conley RR. McMahon RP, et al. Among authors: kelly dl. Neuropsychopharmacology. 2002 Apr;26(4):537-45. doi: 10.1016/S0893-133X(01)00387-6. Neuropsychopharmacology. 2002. PMID: 11927178

3

Circumstances of suicide among individuals with schizophrenia.

Kreyenbuhl JA, Kelly DL, Conley RR. Kreyenbuhl JA, et al. Among authors: kelly dl. Schizophr Res. 2002 Dec 1;58(2-3):253-61. doi: 10.1016/s0920-9964(01)00379-6. Schizophr Res. 2002. PMID: 12409166

4

Rehospitalization risk with second-generation and depot antipsychotics.

Conley RR, Kelly DL, Love RC, McMahon RP. Conley RR, et al. Among authors: kelly dl. Ann Clin Psychiatry. 2003 Mar;15(1):23-31. doi: 10.1023/a:1023276509470. Ann Clin Psychiatry. 2003. PMID: 12839430

5

Atypical antipsychotic use in a state hospital inpatient adolescent population.

Kelly DL, Love RC, MacKowick M, McMahon RP, Conley RR. Kelly DL, et al. J Child Adolesc Psychopharmacol. 2004 Spring;14(1):75-85. doi: 10.1089/104454604773840517. J Child Adolesc Psychopharmacol. 2004. PMID: 15142394

6

Cardiovascular disease in relation to weight in deceased persons with schizophrenia.

Conley RR, Shim JC, Kelly DL, Feldman S, Yu Y, McMahon RP. Conley RR, et al. Among authors: kelly dl. Compr Psychiatry. 2005 Nov-Dec;46(6):460-7. doi: 10.1016/j.comppsych.2005.03.007. Compr Psychiatry. 2005. PMID: 16275214

7

Adjunct divalproex or lithium to clozapine in treatment-resistant schizophrenia.

Kelly DL, Conley RR, Feldman S, Yu Y, McMahon RP, Richardson CM. Kelly DL, et al. Psychiatr Q. 2006 Spring;77(1):81-95. doi: 10.1007/s11126-006-7963-9. Psychiatr Q. 2006. PMID: 16397757

8

Reaching for wellness in schizophrenia.

Kelly DL, Boggs DL, Conley RR. Kelly DL, et al. Psychiatr Clin North Am. 2007 Sep;30(3):453-79. doi: 10.1016/j.psc.2007.04.003. Psychiatr Clin North Am. 2007. PMID: 17720032 Review.

9

Feasibility of reducing the duration of placebo-controlled trials in schizophrenia research.

McMahon RP, Kelly DL, Boggs DL, Li L, Hu Q, Davis JM, Carpenter WT Jr. McMahon RP, et al. Among authors: kelly dl. Schizophr Bull. 2008 Mar;34(2):292-301. doi: 10.1093/schbul/sbm152. Epub 2008 Jan 8. Schizophr Bull. 2008. PMID: 18184634 Free PMC article.

10

Comparison of clozapine response for inpatients in the research setting versus routine clinical practice.

Boggs DL, Kelly DL, Love RC, McMahon RP, Conley RR. Boggs DL, et al. Among authors: kelly dl. Psychiatr Q. 2008 Jun;79(2):111-9. doi: 10.1007/s11126-008-9067-1. Epub 2008 Jan 24. Psychiatr Q. 2008. PMID: 18214677 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

426 results

Search Page

Filters